ASEP Medical Holdings Inc. Stock OTC Markets
Equities
SEPSF
CA04368A1057
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1 USD | +100.00% |
|
+100.00% | -43.41% |
Sales 2022 | - | Sales 2023 | 21.14K 15.44K | Capitalization | 14.4M 10.52M |
---|---|---|---|---|---|
Net income 2022 | -4M -2.92M | Net income 2023 | -8M -5.84M | EV / Sales 2022 | - |
Net cash position 2022 | 3.28M 2.4M | Net cash position 2023 | 205K 150K | EV / Sales 2023 | 672 x |
P/E ratio 2022 |
-7.95
x | P/E ratio 2023 |
-1.55
x | Employees | 7 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 96.87% |
1 day | +100.00% | ||
1 week | +100.00% | ||
Current month | +100.00% | ||
1 month | +100.00% | ||
3 months | +100.00% | ||
6 months | -43.41% | ||
Current year | -43.41% |
![Extreme 0.1](/images/extremecours_fleche.png)
![Extreme 0.1](/images/extremecours_fleche.png)
![Extreme 0.05](/images/extremecours_fleche.png)
![Extreme 0.05](/images/extremecours_fleche.png)
![Extreme 0.05](/images/extremecours_fleche.png)
![Extreme 0.05](/images/extremecours_fleche.png)
![Extreme 0.05](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Robert Hancock
CEO | Chief Executive Officer | 75 | 21-01-19 |
Director of Finance/CFO | 68 | 22-09-30 | |
Rob Stenstrom
CTO | Chief Tech/Sci/R&D Officer | - | 23-02-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Hancock
CEO | Chief Executive Officer | 75 | 21-01-19 |
Derrold Norgaard
BRD | Director/Board Member | 62 | 21-11-08 |
Timothy Murphy
COO | Chief Operating Officer | 53 | 21-11-08 |
1st Jan change | Capi. | |
---|---|---|
+38.65% | 39.1B | |
-8.62% | 38.76B | |
+26.95% | 31.24B | |
+10.74% | 25.9B | |
-13.50% | 25.8B | |
+44.87% | 14.06B | |
+34.36% | 13.12B | |
-7.14% | 11.32B | |
-12.61% | 10.68B |
- Stock Market
- Equities
- ASEP Stock
- SEPSF Stock